Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H20N2O2 |
Molecular Weight | 308.3743 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=VYMDGNCVAMGZFE-UHFFFAOYSA-N
InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3
Molecular Formula | C19H20N2O2 |
Molecular Weight | 308.3743 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:04 UTC 2023
by
admin
on
Fri Dec 15 15:16:04 UTC 2023
|
Record UNII |
GN5P7K3T8S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 522.1720
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
CFR |
21 CFR 520.1720D
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
CFR |
21 CFR 520.1720
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
CFR |
21 CFR 520.1720B
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
CFR |
21 CFR 520.1720C
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
CFR |
21 CFR 520.1720A
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
WHO-VATC |
QM02AA01
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
CFR |
21 CFR 520.1720E
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
WHO-VATC |
QM01BA01
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
WHO-ATC |
M02AA01
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
IARC | Phenylbutazone | ||
|
WHO-VATC |
QM01AA01
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
WHO-ATC |
M01BA01
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
||
|
WHO-ATC |
M01AA01
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8660
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | Merck Index | ||
|
1531007
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
CHEMBL101
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
GN5P7K3T8S
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
PHENYLBUTAZONE
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
8160
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | RxNorm | ||
|
C66377
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
200-029-0
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
DTXSID9021136
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
SUB09787MIG
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
50-33-9
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
4781
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
100000092182
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
7270
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
3159
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
DB00812
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
4
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
25134
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
GN5P7K3T8S
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
48574
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
2145
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY | |||
|
D010653
Created by
admin on Fri Dec 15 15:16:04 UTC 2023 , Edited by admin on Fri Dec 15 15:16:04 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
SALT/SOLVATE -> PARENT | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
Metabolite to parent drug ratio in non-uraemic human plasma.
METABOLITE TO PARENT DRUG RATIO
PLASMA; URINE
|
||
|
METABOLITE ACTIVE -> PARENT |
Oxyphenbutazone, having the same antirheumatic and sodium retaining activities as phenylbutazone, is in clinical use.
|
||
|
METABOLITE ACTIVE -> PARENT |
Percent of dose excreted in urine as metabolite.
AMOUNT ADMINISTERED
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.55
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |